Glioma and microenvironment dual targeted nanocarrier for improved antiglioblastoma efficacy

References

• Abe K, Shoji M, Chen J, et al. (1999). Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc Natl Acad Sci USA 96:8663–8.
   PubMed Web of Science ®Google Scholar
• Bardos H, Molnar P, Csecsei G, Adany R. (1996). Fibrin deposition in primary and metastatic human brain tumours. Blood Coagul Fibrinolysis 7:536–48.
   PubMed Web of Science ®Google Scholar
• Bianco J, Bastiancich C, Jankovski A, et al. (2017). On glioblastoma and the search for a cure: where do we stand? Cell Mol Life Sci 74:2451–66.
   PubMed Web of Science ®Google Scholar
• Boucher Y, Baxter LT, Jain RK. (1990). Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res 50:4478–84.
   PubMed Web of Science ®Google Scholar
• Brown CE, Starr R, Aguilar B, et al. (2012). Stem-like tumor-initiating cells isolated from IL13Ralpha2 expressing gliomas are targeted and killed by IL13-zetakine-redirected T Cells. Clin Cancer Res 18:2199–209.
   PubMed Web of Science ®Google Scholar
• Campos B, Olsen LR, Urup T, Poulsen HS. (2016). A comprehensive profile of recurrent glioblastoma. Oncogene 35:5819–25.
   PubMed Web of Science ®Google Scholar
• Chen C, Duan Z, Yuan Y, et al. (2017). Peptide-22 and cyclic RGD functionalized liposomes for glioma targeting drug delivery overcoming BBB and BBTB. ACS Appl Mater Interfaces 9:5864–73.
   PubMed Web of Science ®Google Scholar
• Chung EJ, Cheng Y, Morshed R, et al. (2014). Fibrin-binding, peptide amphiphile micelles for targeting glioblastoma. Biomaterials 35:1249–56.
   PubMed Web of Science ®Google Scholar
• Colombo MC, Giverso C, Faggiano E, et al. (2015). Towards the personalized treatment of glioblastoma: integrating patient-specific clinical data in a continuous mechanical model. PLoS One 10:e0132887.
   PubMed Web of Science ®Google Scholar
• Debinski W, Gibo DM, Hulet SW, et al. (1999). Receptor for interleukin 13 is a marker and therapeutic target for human high-grade gliomas. Clin Cancer Res 5:985–90.
   PubMed Web of Science ®Google Scholar
• Deeken JF, Loscher W. (2007). The blood-brain barrier and cancer: transporters, treatment, and Trojan horses. Clin Cancer Res 13:1663–74.
   PubMed Web of Science ®Google Scholar
• Fuller GN, Scheithauer BW. (2007). The 2007 Revised World Health Organization (WHO) Classification of Tumours of the Central Nervous System: newly codified entities. Brain Pathol 17:304–7.
   PubMed Web of Science ®Google Scholar
• Hershey GK. (2003). IL-13 receptors and signaling pathways: an evolving web. J Allergy Clin Immunol 111:677–90.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Wang X, Liu X, et al. (2017). Enhanced antiglioma efficacy of ultrahigh loading capacity paclitaxel prodrug conjugate self-assembled targeted nanoparticles. ACS Appl Mater Interfaces 9:211–17.
   PubMed Web of Science ®Google Scholar
• Jo J, Schiff D, Purow B. (2012). Angiogenic inhibition in high-grade gliomas: past, present and future. Expert Rev Neurother 12:733–47.
   PubMed Web of Science ®Google Scholar
• Juillerat-Jeanneret L. (2008). The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles? Drug Discov Today 13:1099–106.
   PubMed Web of Science ®Google Scholar
• Kim SS, Harford JB, Pirollo KF, Chang EH. (2015a). Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: the promise of nanomedicine. Biochem Biophys Res Commun 468:485–9.
   PubMed Web of Science ®Google Scholar
• Kim SS, Rait A, Kim E, et al. (2015b). A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme. Nanomedicine 11:301–11.
   PubMed Web of Science ®Google Scholar
• Lu F, Pang Z, Zhao J, et al. (2017). Angiopep-2-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) polymersomes for dual-targeting drug delivery to glioma in rats.Int J Nanomed 12:2117–27.
   PubMed Web of Science ®Google Scholar
• Malik G, Knowles LM, Dhir R, et al. (2010). Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion. Cancer Res 70:4327–34.
   PubMed Web of Science ®Google Scholar
• Ostrom QT, Gittleman H, Liao P, et al. (2014). CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro Oncol 16:1–63.
   PubMed Web of Science ®Google Scholar
• Pandya H, Gibo DM, Garg S, et al. (2012). An interleukin 13 receptor alpha 2-specific peptide homes to human glioblastoma multiforme xenografts. Neuro Oncol 14:6–18.
   PubMed Web of Science ®Google Scholar
• Perez-Herrero E, Fernandez-Medarde A. (2015). Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm 93:52–79.
   PubMed Web of Science ®Google Scholar
• Petrecca K, Guiot MC, Panet-Raymond V, Souhami L. (2013). Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma. J Neurooncol 111:19–23.
   PubMed Web of Science ®Google Scholar
• Sarin H, Kanevsky AS, Wu H, et al. (2009). Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors. J Transl Med 7:51.
   PubMed Web of Science ®Google Scholar
• Sehedic D, Cikankowitz A, Hindre F, et al. (2015). Nanomedicine to overcome radioresistance in glioblastoma stem-like cells and surviving clones. Trends Pharmacol Sci 36:236–52.
   PubMed Web of Science ®Google Scholar
• Simberg D, Duza T, Park JH, et al. (2007). Biomimetic amplification of nanoparticle homing to tumors. Proc Natl Acad Sci USA104:932–6.
   PubMed Web of Science ®Google Scholar
• Sonali Agrawal P, Singh RP, et al. (2016). Transferrin receptor-targeted vitamin E TPGS micelles for brain cancer therapy: preparation, characterization and brain distribution in rats. Drug Deliv 23:1788–98.
   PubMed Web of Science ®Google Scholar
• Song Y, Huang Z, Xu J, et al. (2014). Multimodal SPION-CREKA peptide based agents for molecular imaging of microthrombus in a rat myocardial ischemia-reperfusion model. Biomaterials 35:2961–70.
   PubMed Web of Science ®Google Scholar
• Van Tellingen O, Yetkin-Arik B, De Gooijer MC, et al. (2015). Overcoming the blood-brain tumor barrier for effective glioblastoma treatment. Drug Resist Updat 19:1–12.
   PubMed Web of Science ®Google Scholar
• Wang B, Lv L, Wang Z, et al. (2014). Nanoparticles functionalized with Pep-1 as potential glioma targeting delivery system via interleukin 13 receptor alpha2-mediated endocytosis. Biomaterials 35:5897–907.
   PubMed Web of Science ®Google Scholar
• Wang C, Wang X, Zhong T, et al. (2015). The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo. Int J Nanomedicine 10:2229–48.
   PubMed Web of Science ®Google Scholar
• Yang A, Yang L, Liu W, et al. (2007). Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation. Int J Pharm 331:123–32.
   PubMed Web of Science ®Google Scholar
• Ye F, Wu X, Jeong EK, et al. (2008). A peptide targeted contrast agent specific to fibrin-fibronectin complexes for cancer molecular imaging with MRI. Bioconjug Chem 19:2300–3.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhai M, Chen Z, et al. (2017). Dual-modified liposome codelivery of doxorubicin and vincristine improve targeting and therapeutic efficacy of glioma. Drug Deliv 24:1045–55.
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhang B, Shen S, et al. (2015). CREKA peptide-conjugated dendrimer nanoparticles for glioblastoma multiforme delivery. J Colloid Interface Sci 450:396–403.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Qutaish M, Han Z, et al. (2015). MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent. Nat Commun 6:7984.
   PubMed Web of Science ®Google Scholar